New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
08:02 EDTNWBONorthwest receives recommendation to continue with Phase III brain cancer trial
Northwest Biotherapeutics announced, in response to shareholder inquiries, that the Data Safety Monitoring Board has made an unblinded review of the safety data for the company's ongoing international Phase III GBM Trial, and has recommended that the trial continue as planned. The DSMB's review of the efficacy data is still pending.
News For NWBO From The Last 14 Days
Check below for free stories on NWBO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 19, 2014
10:42 EDTNWBOOptions with decreasing implied volatility
Subscribe for More Information
August 13, 2014
09:32 EDTNWBONorthwest Biotherapeutics says claims by Feuerstein about DCVax trial 'false'
Subscribe for More Information
09:30 EDTNWBONorthwest Biotherapeutics says claims by Feuerstein about DCVax trial 'false'
Subscribe for More Information
August 12, 2014
11:27 EDTNWBONorthwest Bio trial changes 'hint at failure,' TheStreet's Feuerstein says
Subscribe for More Information
August 11, 2014
08:16 EDTNWBONorthwest Biotherapeutics obtains approvals for enhancements of DCVAX trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use